Categories: Health Care

Cancer Causing Bacteria Gains Antibiotic Resistance, Finds KMC Scientists

New Delhi, July 10, 2019: A study by the Kasturba Medical College and tertiary care hospital said to be first of its kind from Karnataka has found that Helicobacter pylori, a bacterium that resides in the human stomach and causes ulcers, gastritis and stomach cancers, has gained resistance to three commonly used antibiotics – metronidazole, levofloxacin and clarithromycin that the drugs may not be able to provide relief anymore.

This important finding was the result of the joint collaboration of KMC, MAHE Scientists and Scientists from Marshall Centre, The University of Western Australia. The KMC Scientists were: Dr. Mamatha Ballal (Team Lead), Dr. Vignesh Shetty, Dr. Ganesh Pai, Dr. Ramachandra L, Dr. Shiran Shetty and the UWA Scientists: Dr. Alfred Tay, Dr. Eng Guan Chua, Mr. Binit Lamichhane.

The study was aimed to gain insight on the prevalence and mechanism of drug resistance in Helicobacter linked diseases so as to help develop strategies with more rational antibiotic combinations for treatment. This will also help implement precise therapy and thus prevent recurrence of the infections.

Speaking on the occasion Dr. Pragna Rao, Dean, KMC, “The KMC team was a truly interdisciplinary team which put together expertise across disciplines to reach this findings. Dr. Vignesh Shetty trained with a Nobel Laureate, Professor Barry Marshall. Using highly advanced methods and skills, what could have remained as a lab bench technique has been brought to the bedside for better patient care.”

This study can act as a strong foundation to progress in national epidemiological surveillance which will be beneficial in evidence-based treatment and also as a managerial follow-up of eradication of Helicobacter if the first line treatment fails. The working group at KMC in future plans to come out with a rapid kit for detection of drug resistance in bacteria, which would help clinicians to modulate treatment regimen.

Newsvoir

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

5 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

23 hours ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

4 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

5 days ago